Extended-spectrum beta-lactamase producing enterobacteriaceae in a tertiary care hospital in Trinidad and Tobago

West Indian Medical Journal

Volumn 52, Issue 1, 2003, Pages 31-33

  Cherian, B P ^a,b   Manjunath, M ^a,b   Pinto Pereira, L M ^a,b   Prabhakar, P ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b Caribbean Epidemiology Centre   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE;

ALERTNESS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CENTRAL AMERICA; CITROBACTER; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA; ESCHERICHIA COLI; HEALTH SURVEY; HOSPITAL PATIENT; INFECTION CONTROL; KLEBSIELLA; NONHUMAN; PROTEUS; PROVIDENCIA; SCREENING TEST; SERRATIA; TRINIDAD AND TOBAGO;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ENTEROBACTERIACEAE; HUMANS; TRINIDAD AND TOBAGO;

EID: 0037731476     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sanders CC, Sanders WE Jr. Beta-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15: 824-39.
2. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific Region. Clin Infect Dis 2001; 32 (Suppl 2): 94-103.
3. Kliebe C, Nies BA, Meyer JF, Tolxodorff- Neutzling RM, Weidmann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302-7.
4. Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32: 1085-7.
5. Moosdeen F. The evolution of resistance to cephalosporins. Clin Infect Dis 1997; 24: 487-93.
6. Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generation of beta-lactam antibiotics. Clin Infect Dis 1997; 24 (Suppl 1): 19-45.
7. Jacobson KL, Cohen SH, Inciardi JF, King JH, Lippert WE, Iglesias T et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group 1 beta-lactamase-producing organisms. Clin Infect Dis 1995; 21: 1107-13.
8. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
9. Morosini MI, Canton R, Martinez-Beltran J, Negri MC, Perez- Diaz JC, Bequero F et al. New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother 1995; 39: 458-61.
10. Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazmierczak A. Outbreak of TEM-24 producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended spectrum beta-lactamase to other members of the family enterobacteriaceae. J Clin Microbiol 1996; 34: 76-9.
11. Rice LB, Willey SH, Papanicolaou GB, Medeiros AA, Eliapoulos GH, Moellering RC Jr et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimirob Agents Chemother 1990; 34: 2193-9.
12. Rice LB, Eckstein EC, De Vente J, Shlaes JM. Ceftazidime-resistant Klebisella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118-24.
13. Prabhakar P, Ali C, Swanston WH, White H, Whitebourne F. Antibiotic resistance patterns of gram negative aerobic bacilli: A Caribbean collaborative study. West Indian Med J 1992; 41(Suppl): 53.
14. Prabhakar P and the Caribbean Antimicrobial Resistance Surveillance Group. Antimicrobial Resistance in the Caribbean. West Indian Med J 2000. 49 (Suppl 2): 62.
15. National Committee for Clinical Laboratory Standards. Performance for antimicrobial disc susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards. Villanova, PA. 1993.
16. Thomson KS, Sanders CC. Detection of extended-spectrum beta-lactamases in members of the family of Enterobacteraiceae: comparison of the double-disk and the three-dimensional tests. Antimicrob Agents Chemother 1992; 36: 1877-82.
17. Levett PN, Holt HA, McGowan AP. Resistance to third-generation cephalosporins in Barbados. West Indian Med J 1993; 42: 69-71.
18. Bodonaik NC, Sue H, Richard W, Chen WN. Evaluation of antibacterial activity of cefotaxime after eight years of its usage at the University of the West Indies. West Indian Med J 1993; 42 (Suppl): 29-30.
19. Cherian BP, Singh N, Charles W, Prabhakar P. Extended-spectrum beta-lactamase producing Salmonella enteritidis in Trinidad and Tobago. Emerg Infect Dis 1999; 5: 181-2.
20. Sanders WE Jr. Sanders CC. Enterobacter spp: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997; 10: 220-41.
21. Lautenback E, Patel JB, Bilker WB, Edelstein-PH, Fishman NO. Extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71.
22. Jacoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996; 34: 908-11.